Abstract: Various embodiments of smart thermostats are presented herein. A smart thermostat can include a thermostat housing defining a rounded front aperture and having a sidewall. The smart thermostat can include a capacitive touch strip that senses a plurality of gestures. The smart thermostat can include an electronic display. The electronic display may be caused to display icons arranged in a graphical arc. The smart thermostat may include a reflective cover positioned such that the electronic display is viewed through the reflective cover.

Abstract: Various embodiments of smart thermostats are presented herein. A smart thermostat can include a thermostat housing defining a rounded front aperture and having a sidewall. The smart thermostat can include a capacitive touch strip that senses a plurality of gestures. The smart thermostat can include an electronic display. The electronic display may be caused to display icons arranged in a graphical arc. The smart thermostat may include a reflective cover positioned such that the electronic display is viewed through the reflective cover.

Abstract: Various embodiments of smart thermostats are presented herein. A smart thermostat can include a thermostat housing defining a rounded front aperture and having a sidewall. The smart thermostat can include a capacitive touch strip that senses a plurality of gestures. The smart thermostat can include an electronic display. The electronic display may be caused to display icons arranged in a graphical arc. The smart thermostat may include a reflective cover positioned such that the electronic display is viewed through the reflective cover.

Abstract: Various embodiments of smart thermostats are presented herein. A smart thermostat can include a thermostat housing defining a rounded front aperture and having a sidewall. The smart thermostat can include a capacitive touch strip that senses a plurality of gestures. The smart thermostat can include an electronic display. The electronic display may be caused to display icons arranged in a graphical arc. The smart thermostat may include a reflective cover positioned such that the electronic display is viewed through the reflective cover.

Abstract: A system and bin monitoring units are adapted to monitor the status of plurality of garbage bins and to collect bins status in a central service unit, to store and analyze the status of the garbage bins and to control the operation and collection travel plans of garbage field service units that comprise garbage collection trucks and garbage collection stuff.

Abstract: The present invention provides a method for treating or preventing one or more types of migraines by administering a monoamine oxidase inhibitor, preferably Isocarboxazid, to a patient without invoking hypertensive crisis.

Abstract: The invention is a gel composition for delivery to a breast milk duct prior to surgical excision of breast tissue including cancerous lesions. The invention also provides methods of mapping all or nearly all of a breast milk duct prior to surgical excision of breast tissue, and method of identifying part or all of a breast duct or ducts as a surgical aide to a breast surgeon. Kits to support these methods and including these compositions are also provided.

Abstract: The invention is a gel composition for delivery to a breast milk duct prior to surgical excision of breast tissue including cancerous lesions. The invention also provides methods of mapping all or nearly all of a breast milk duct prior to surgical excision of breast tissue, and method of identifying part or all of a breast duct or ducts as a surgical aide to a breast surgeon. Kits to support these methods and including these compositions are also provided.

Abstract: The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments further comprises a pharmaceutically active agent. The invention also relates to a method for the treatment of a benign ovarian secretory disorder in a female mammal, a method of contraception, and a method of relieving the symptoms associated with menopausal, perimenopausal and post-menopausal periods in a woman.

Abstract: The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation comprising an agonist of endothelial nitric oxide synthase (eNOS), such as an HMG-CoA reductase inhibitor, and a formulation comprising a precursor of NO, such as L-arginine, may be used to treat or prevent cerebrovascular and/or cardiovascular diseases or disorders.

Abstract: The present invention provides methods for using L-arginine formulations, such as sustained release formulations, for various indications, including lowering triglyceride levels, inducing thermogenesis, weight loss and treatment and prevention of obesity and obesity related conditions, such as diabetes. Moreover, the present invention provides methods for treating or preventing other indications, such as asthma.

Abstract: The present invention provides methods for using L-arginine formulations, such as sustained release formulations, for various indications, including lowering triglyceride levels, inducing thermogenesis, weight loss and treatment and prevention of obesity and obesity related conditions, such as diabetes. Moreover, the present invention provides methods for treating or preventing other indications, such as asthma.

Abstract: The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation comprising an agonist of endothelial nitric oxide synthase (eNOS), such as an HMG-CoA reductase inhibitor, and a formulation comprising a precursor of NO, such as L-arginine, may be used to treat or prevent cerebrovascular and/or cardiovascular diseases or disorders.

Abstract: A method and compositions are provided for increased cerebral bioavailability of blood-born compositions by administering the composition of interest while increasing production of NO by eNOS, especially by administering L-arginine, by administering agents that increase NO levels independent of ecNOS, or by any combination of these methods. As NO is increased, cerebral blood flow is consequently increased, and drugs in the blood stream are carried along with the increased flow into brain tissue. By increased flow, the site of action will be exposed to more drug molecules. By stimulating increased NO production, administration of drugs that are not easily introduced to the brain may be facilitated and/or the serum concentration necessary to achieve desired physiologic effects may be reduced.

Abstract: The invention is a gel composition for delivery to a breast milk duct prior to surgical excision of breast tissue including cancerous lesions. The invention also provides methods of mapping all or nearly all of a breast milk duct prior to surgical excision of breast tissue, and method of identifying part or all of a breast duct or ducts as a surgical aide to a breast surgeon. Kits to support these methods and including these compositions are also provided.

Abstract: The invention is a gel composition for delivery to a breast milk duct prior to surgical excision of breast tissue including cancerous lesions. The invention also provides methods of mapping all or nearly all of a breast milk duct prior to surgical excision of breast tissue, and method of identifying part or all of a breast duct or ducts as a surgical aide to a breast surgeon. Kits to support these methods and including these compositions are also provided.

Abstract: An insecticidal device is provided which has a panel of a color having insect attracting properties, preferably yellow, and a spherical body of another color, preferably red. The spherical body is capable of defusing a liquid which contains an insect attractant and is combined with the panel in a manner that they form together an essentially flat panel having hemispherical bulges formed by the spherical body. A specific panel, which can be used as a panel in the above device and can be used as an independent insecticidal device is also provided.

Abstract: A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and an osteogenic protein-sequestering material.

Abstract: A liquid diffuser device is disclosed that includes a liquid holding container having a neck portion that extends from the bottom wall thereof. A base portion is associated with the container, such that the liquid holding container and the base portion are slidably longitudinally movable relative to one another between an uppermost position and a lowermost position. The base portion is provided for tightly sealing the discharge opening of the neck portion. In the uppermost position, the discharge opening is engaged and tightly sealed, so that the flow of liquid from the container through the neck portion is prevented. In the lowermost position, the discharge opening is not sealed, so that the flow of fluid through the discharge opening is permitted.

Abstract: A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a porous particulate polymer matrix; and an osteogenic protein-sequestering amount of blood clot.